Advanced-inoperable cervical cancer is a challenging entity due to increased percentage of
locoregional and distant recurrences. Furthermore, recurrent cervical cancer not amenable …

It is not an exaggeration to state that most of the advances in curing cancer in the last
decade have come from successful combinations of conventional chemotherapeutic agents …

Abstract Programmed death-ligand 1 (PD-L1) is expressed in various immune cells and
tumor cells, and is able to bind to PD-1 on T lymphocytes, thereby inhibiting their function. At …

Purpose To determine whether addition of gemcitabine to concurrent cisplatin
chemoradiotherapy and as adjuvant chemotherapy with cisplatin improves progression-free …

Tissue hypoxia is a characteristic property of cervical cancers that makes tumors resistant to
chemo-and radiation therapy. Erythropoietin (Epo) is a hypoxia-inducible stimulator of …

Radiation therapy (RT) is a common adjunct therapy in oncology. However, it carries a
significant risk of lymphedema when utilized in some anatomic locations. Recent studies …

OBJECTIVE.: To assess the efficacy of systematic lymphadenectomy and adjuvant
radiotherapy in minimizing pelvic sidewall and para-aortic failures. METHODS.: Between …

On a global scale, cancer is a disease with a tremendous effect on the human population,
and has a constant need of new medicines. Scientific and research interest is drawing its …

The combination of radiotherapy (RT) and photothermal therapy (PTT) has been considered
an attractive strategy in cervical cancer treatment. However, it remains a challenge to …

Background Current standard treatment for patients with cervical cancer who have locally
advanced stage disease (International Federation of Gynecology and Obstetrics (FIGO) …